Mind Medicine (MindMed) Inc. Board of Directors

Mind Medicine (MindMed) Inc., a clinical stage biopharmaceutical company, develops novel products to treat brain health disorders. The company's lead product candidates include MM-120, which is in phase 2 for the treatment of generalized anxiety disorder and attention deficit hyperactivity disorder; and MM-402, a R-enantiomer of 3,4-methylenedioxymethamphetamine, which is in phase I clinical trials for the treatment of core symptoms of autism spectrum disorder. Mind Medicine (MindMed) Inc. is headquartered in New York, New York.

Ms. Stephanie Fagan

Ms. Stephanie Fagan

Chief Corporate Affairs Officer

Mr. Mark R. Sullivan J.D.

Mr. Mark R. Sullivan J.D.

Chief Legal Officer & Corporate Secretary

Dr. Gregg Pratt Ph.D.

Dr. Gregg Pratt Ph.D.

Chief Regulatory & Quality Assurance Officer

Ms. Carrie F. Liao CPA, CGMA

Ms. Carrie F. Liao CPA, CGMA

VP & Chief Accounting Officer

Dr. Scott M. Freeman M.D.

Dr. Scott M. Freeman M.D.

Co-Founder & Clinical Advisor

Leaving Board of Directors Review Your about to visit the following url Invalid URL

Loading...
Comments


Comment created.